Literature DB >> 35290443

Deletion of Gdf15 Reduces ER Stress-induced Beta-cell Apoptosis and Diabetes.

Guanlan Xu1,2, Junqin Chen1,2, SeongHo Jo1,2, Truman B Grayson1, Sasanka Ramanadham1,3, Akio Koizumi4, Emily L Germain-Lee5,6, Se-Jin Lee7,8, Anath Shalev1,2.   

Abstract

Endoplasmic reticulum (ER) stress contributes to pancreatic beta-cell apoptosis in diabetes, but the factors involved are still not fully elucidated. Growth differentiation factor 15 (GDF15) is a stress response gene and has been reported to be increased and play an important role in various diseases. However, the role of GDF15 in beta cells in the context of ER stress and diabetes is still unclear. In this study, we have discovered that GDF15 promotes ER stress-induced beta-cell apoptosis and that downregulation of GDF15 has beneficial effects on beta-cell survival in diabetes. Specifically, we found that GDF15 is induced by ER stress in beta cells and human islets, and that the transcription factor C/EBPβ is involved in this process. Interestingly, ER stress-induced apoptosis was significantly reduced in INS-1 cells with Gdf15 knockdown and in isolated Gdf15 knockout mouse islets. In vivo, we found that Gdf15 deletion attenuates streptozotocin-induced diabetes by preserving beta cells and insulin levels. Moreover, deletion of Gdf15 significantly delayed diabetes development in spontaneous ER stress-prone Akita mice. Thus, our findings suggest that GDF15 contributes to ER stress-induced beta-cell apoptosis and that inhibition of GDF15 may represent a novel strategy to promote beta-cell survival and treat diabetes.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ER stress; GDF15; apoptosis; beta cells; diabetes

Mesh:

Substances:

Year:  2022        PMID: 35290443      PMCID: PMC9272264          DOI: 10.1210/endocr/bqac030

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   5.051


  57 in total

1.  Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action.

Authors:  Lance A Thielen; Junqin Chen; Gu Jing; Omar Moukha-Chafiq; Guanlan Xu; SeongHo Jo; Truman B Grayson; Brian Lu; Peng Li; Corinne E Augelli-Szafran; Mark J Suto; Matt Kanke; Praveen Sethupathy; Jason K Kim; Anath Shalev
Journal:  Cell Metab       Date:  2020-07-28       Impact factor: 27.287

2.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.

Authors:  John B Welsh; Lisa M Sapinoso; Suzanne G Kern; David A Brown; Tao Liu; Asne R Bauskin; Robyn L Ward; Nicholas J Hawkins; David I Quinn; Pamela J Russell; Robert L Sutherland; Samuel N Breit; Christopher A Moskaluk; Henry F Frierson; Garret M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

3.  Growth Differentiation Factor 15 Mediates Systemic Glucose Regulatory Action of T-Helper Type 2 Cytokines.

Authors:  Seong Eun Lee; Seul Gi Kang; Min Jeong Choi; Saet-Byel Jung; Min Jeong Ryu; Hyo Kyun Chung; Joon Young Chang; Yong Kyung Kim; Ju Hee Lee; Koon Soon Kim; Hyun Jin Kim; Heung Kyu Lee; Hyon-Seung Yi; Minho Shong
Journal:  Diabetes       Date:  2017-09-05       Impact factor: 9.461

4.  The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.

Authors:  Greisa Vila; Michaela Riedl; Christian Anderwald; Michael Resl; Ammon Handisurya; Martin Clodi; Gerhard Prager; Bernhard Ludvik; Michael Krebs; Anton Luger
Journal:  Clin Chem       Date:  2010-12-16       Impact factor: 8.327

Review 5.  Roles of CHOP/GADD153 in endoplasmic reticulum stress.

Authors:  S Oyadomari; M Mori
Journal:  Cell Death Differ       Date:  2004-04       Impact factor: 15.828

Review 6.  Concise review: growth differentiation factor 15 in pathology: a clinical role?

Authors:  Jill Corre; Benjamin Hébraud; Philippe Bourin
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

7.  Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.

Authors:  Tibor Kempf; Anja Guba-Quint; Jarl Torgerson; Maria Chiara Magnone; Carolina Haefliger; Maria Bobadilla; Kai C Wollert
Journal:  Eur J Endocrinol       Date:  2012-08-23       Impact factor: 6.664

8.  NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development.

Authors:  Nivedita M Ratnam; Jennifer M Peterson; Erin E Talbert; Katherine J Ladner; Priyani V Rajasekera; Carl R Schmidt; Mary E Dillhoff; Benjamin J Swanson; Ericka Haverick; Raleigh D Kladney; Terence M Williams; Gustavo W Leone; David J Wang; Denis C Guttridge
Journal:  J Clin Invest       Date:  2017-09-11       Impact factor: 14.808

9.  Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Pablo Avanzas
Journal:  Am J Cardiol       Date:  2014-07-02       Impact factor: 2.778

10.  NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway.

Authors:  K-W Min; J L Liggett; G Silva; W W Wu; R Wang; R-F Shen; T E Eling; S J Baek
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.